Large-scale testing (Phase 3)Ended earlyNCT01901341
What this trial is testing
The Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Who this might be right for
Opioid-Induced Constipation
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 44